Prostate Grand Rounds – Decatur, TX
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
12 events found.
HCC Specialty Series – Thomas Cartwright, MD
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
Rethinking HCC – Brooklyn, NY
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
Hemophilia A – Nashville, TN
Meharry Medical College 1005 Dr. D.B.Todd Jr. Blvd, Nashville, TN, United StatesThis case-based live activity will cover the treatment and management of patients with hemophilia A
Rethinking HCC – Greenwood, SC
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies – Grand Junction, CO
This activity will cover the treatment and management of patients with AML and CLL.
CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Lansing, MI
Sparrow Health - Herbert-Herman Cancer Center 1140 E Michigan Ave, Lansing, MI, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
Rethinking HCC – San Francisco, CA (PST)
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
HCC Specialty Series – Michael Morse, MD
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
Rethinking HCC – Marlborough, MA
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies
This activity will cover the treatment and management of patients with AML and CLL.
Rethinking HCC – Philadelphia, PA
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).